Proficio Capital Partners LLC Axogen, Inc. Transaction History

Proficio Capital Partners LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$12.09 - $20.46 $294,875 - $499,019	-24,390 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$18.5 - $25.47 $229,030 - $315,318	-12,380 Reduced 33.67%	24,390 $483,000
Q1 2019 May 13, 2019	SELL	$14.62 - $22.13 $190,060 - $287,690	-13,000 Reduced 26.12%	36,770 $774,000
Q4 2018 Feb 08, 2019	BUY	$17.09 - $38.25 $117,493 - $262,968	6,875 Added 16.03%	49,770 $1.02 Million
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $98,574 - $161,830	2,895 Added 7.24%	42,895 $1.58 Million

Q2 2018 Aug 10, 2018	SELL	$36.15 - $52.5 $108,450 - $157,500	-3,000 Reduced 6.98%	40,000 $2.01 Million
Q1 2018 May 14, 2018	SELL	$24.4 - $40.25 $600,240 - $990,150	-24,600 Reduced 36.39%	43,000 $1.57 Million
Q4 2017 Feb 09, 2018	BUY	$18.5 - $28.6 $66,600 - $102,960	3,600 Added 5.63%	67,600 $1.91 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $937,600 - $1.24 Million	64,000	64,000 $1.24 Million

126

34.1M

80.7K

3.3K

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $318M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.